MetLife, Inc. (NYSE:MET) Receives $92.46 Average PT from Brokerages

Shares of MetLife, Inc. (NYSE:METGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $92.46.

A number of brokerages recently issued reports on MET. Wells Fargo & Company dropped their price objective on MetLife from $97.00 to $91.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Keefe, Bruyette & Woods dropped their price objective on MetLife from $98.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Piper Sandler lifted their price target on MetLife from $92.00 to $94.00 and gave the company an “overweight” rating in a research report on Wednesday, April 2nd. JPMorgan Chase & Co. cut their price target on shares of MetLife from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, April 2nd. Finally, StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th.

Check Out Our Latest Stock Analysis on MET

Institutional Trading of MetLife

Institutional investors have recently modified their holdings of the company. CX Institutional lifted its holdings in MetLife by 15.9% in the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock worth $5,568,000 after buying an additional 9,337 shares during the period. Bank of New York Mellon Corp increased its position in MetLife by 109.2% during the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider’s stock valued at $722,727,000 after purchasing an additional 4,606,748 shares during the period. Smartleaf Asset Management LLC raised its holdings in MetLife by 27.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 13,692 shares of the financial services provider’s stock worth $1,116,000 after purchasing an additional 2,940 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of MetLife by 1.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 776,244 shares of the financial services provider’s stock valued at $63,559,000 after buying an additional 12,723 shares during the period. Finally, Kingswood Wealth Advisors LLC purchased a new stake in MetLife in the fourth quarter worth about $259,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Stock Up 1.1 %

MetLife stock opened at $72.49 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $49.38 billion, a P/E ratio of 12.14, a P/E/G ratio of 0.65 and a beta of 0.89. The firm has a 50 day moving average price of $79.41 and a 200-day moving average price of $82.19. MetLife has a twelve month low of $65.21 and a twelve month high of $89.05.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, equities analysts predict that MetLife will post 9.65 EPS for the current year.

MetLife Company Profile

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.